Dynavax Technologies Corporation
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersEmeryville, CA
SAM.gov UEIJA7GSG397PL1
Dynavax Technologies is a commercial-stage biopharmaceutical company that develops and commercializes vaccines to prevent infectious diseases using adjuvant technology. The company's marketed product is HEPLISAV-B, an adult hepatitis B vaccine, and it has a Phase 1/2 shingles vaccine candidate in its pipeline. The company utilizes CpG 1018 as its adjuvant technology platform.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Dynavax Technologies Corporation | Emeryville | CA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.